Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia.
暂无分享,去创建一个
Anna Wedell | H. Falhammar | M. Thorén | K. Brismar | Kerstin Brismar | Marja Thorén | A. Wedell | Henrik Falhammar | Helena Filipsson Nyström | H. Filipsson Nyström
[1] S. Khosla,et al. Osteoporosis in men. , 1995, Endocrine reviews.
[2] M. Thorén,et al. Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. , 1999, The Journal of clinical endocrinology and metabolism.
[3] K. Carson,et al. Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia. , 2006, The Journal of clinical endocrinology and metabolism.
[4] H. Falhammar,et al. Clinical outcomes in the management of congenital adrenal hyperplasia , 2012, Endocrine.
[5] J. Winter,et al. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia. , 1997, The Journal of clinical endocrinology and metabolism.
[6] P. Touraine,et al. Hormonal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2007, Annales d'endocrinologie.
[7] R. Eastell,et al. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia , 1996, Clinical endocrinology.
[8] H. Falhammar,et al. Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency. , 2009, The Journal of clinical endocrinology and metabolism.
[9] R. Voutilainen,et al. Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21‐hydroxylase deficiency , 1996, Clinical endocrinology.
[10] S. Mora,et al. Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency. , 2006, The Journal of clinical endocrinology and metabolism.
[11] M. Quinkler,et al. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy. , 2012, The Journal of clinical endocrinology and metabolism.
[12] M. Nishitani,et al. Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia. , 2012, The Journal of clinical endocrinology and metabolism.
[13] C. Gordon,et al. Bone Mineral Status in Children with Congenital Adrenal Hyperplasia , 2007, Journal of pediatric endocrinology & metabolism : JPEM.
[14] G. Chrousos,et al. 5 Glucocorticoid resistance , 1994 .
[15] P. Michel,et al. Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency , 2008 .
[16] H. Falhammar,et al. Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2011, European journal of endocrinology.
[17] K. Nair,et al. Effect of short-term prednisone use on blood flow, muscle protein metabolism, and function. , 2004, The Journal of clinical endocrinology and metabolism.
[18] J. Mindell,et al. The epidemiology of fractures in England , 2008, Journal of Epidemiology & Community Health.
[19] V. Montori,et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. , 2010, The Journal of clinical endocrinology and metabolism.
[20] C. C. Pillai,et al. IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH. , 2001, European journal of endocrinology.
[21] S. Adami,et al. Height, Bone Mineral Density and Bone Markers in Congenital Adrenal Hyperplasia , 2001, Hormone Research in Paediatrics.
[22] C. Mølgaard,et al. Normal Bone Mineral Content in Young Adults with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency , 2004, Hormone Research in Paediatrics.
[23] Li Sun,et al. Minireview: The link between fat and bone: does mass beget mass? , 2012, Endocrinology.
[24] M. de Mello,et al. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density , 2003, Journal of Bone and Mineral Metabolism.
[25] K. Hall,et al. Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. , 1991, Acta endocrinologica.
[26] J. Connell,et al. Health Status of Adults with Congenital Adrenal Hyperplasia: A Cohort Study of 203 Patients , 2010, The Journal of clinical endocrinology and metabolism.
[27] O. Arisaka,et al. Preliminary report: effect of adrenal androgen and estrogen on bone maturation and bone mineral density. , 2001, Metabolism: clinical and experimental.
[28] M. New,et al. 21‐Hydroxylase Deficiency , 1997, Annals of the New York Academy of Sciences.
[29] H. Falhammar,et al. Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia , 2011, European journal of endocrinology.
[30] M. Thorén,et al. Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome. , 1993, Acta endocrinologica.
[31] H. Ringertz,et al. Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy. , 2000, European journal of endocrinology.
[32] R. Rizzoli,et al. Osteoporosis in men. , 2001, The Nursing clinics of North America.
[33] M. New,et al. Congenital adrenal hyperplasia. , 1988, Biochemical Society transactions.
[34] W. Oyen,et al. Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia. , 2003, The Journal of clinical endocrinology and metabolism.
[35] J. Schlechte,et al. The effects of hyperprolactinemia on bone and fat , 2008, Pituitary.
[36] Stefan R Bornstein,et al. Congenital adrenal hyperplasia , 2005, The Lancet.
[37] J. Svartberg,et al. Genetic, anthropometric and metabolic features of adult Norwegian patients with 21-hydroxylase deficiency. , 2012, European journal of endocrinology.
[38] Grant W. Liddie. Clinical pharmacology of the anti‐inflammatory steroids , 1961 .
[39] B. Lukert,et al. Osteoporosis associated with excess glucocorticoids. , 2005, Endocrinology and metabolism clinics of North America.
[40] J. Wark,et al. Bone mineral density and body composition in congenital adrenal hyperplasia. , 1995, The Journal of clinical endocrinology and metabolism.
[41] M. Holick. Vitamin D deficiency. , 2007, The New England journal of medicine.
[42] S. Mora,et al. Bone density in young patients with congenital adrenal hyperplasia. , 1996, Bone.
[43] C. Coldéa,et al. Bone mineral density and bone turnover in Romanian children and young adults with classical 21‐hydroxylase deficiency are influenced by glucocorticoid replacement therapy , 2009, Clinical endocrinology.
[44] R. Adler. 2. Osteoporosis in Men , 2013 .
[45] C. Malchoff,et al. Glucocorticoid Resistance , 2020, Definitions.
[46] H. Falhammar,et al. Fractures and bone mineral density in adult women with 21-hydroxylase deficiency. , 2007, The Journal of clinical endocrinology and metabolism.